Christian Hoenig is a Business Development Director at Quotient Sciences specialising in new business within the Nordic and BeNeLux regions. He has over 10 years experience in preclinical and clinical drug development including 6 years of lab experience in formulation development and in vitro testing in addition to his time in commercial roles.

Christian holds a Masters in Medicinal and Biological Chemistry from Nottingham University, UK where he worked on the development of a novel integrin antagonist for the treatment of pulmonary disorders.